1.
Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nature Reviews
Gastroenterology & Hepatology 10, 686-690 (2013)
2.
Hardy, T. et al. Nonalcoholic fatty liver disease: pathogenesis and disease
spectrum. Annu Rev Pathol. 11, 451–496 (2016)
3.
Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and
pathological severity. Gastroenterology 116, 1413–1419 (1999).
4.
Adams, L. A. et al. The Natural History of Nonalcoholic Fatty Liver Disease: A
Population-Based Cohort Study. Gastroenterology 129, 113-121 (2005)
5.
Krawczyk, M. et al. Combined effects of the PNPLA3 rs738409, TM6SF2
rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter
biopsy-based study. Journal of Lipid Research 58, 247-255 (2017)
6.
Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to
nonalcoholic fatty liver disease. Nature Genetics 40, 1461-1465 (2008)
7.
Eslam, M., Valenti, L. & Romeo, S. Genetics and epigenetics of NAFLD and
NASH: Clinical impact. J Hepatol. 68, 268-279 (2018)
8.
Seko, Y. et al. The genetic backgrounds in nonalcoholic fatty liver disease.
Clinical Journal of Gastroenterology 11, 97-102 (2018)
9.
Huang, Y. et al. Expression and characterization of a PNPLA3 protein isoform
(I148M) associated with nonalcoholic fatty liver disease. J Biol Chem. 286,
37085-37093 (2011)
10.
Pingitore, P. et al. Recombinant PNPLA3 protein shows triglyceride hydrolase
- 47 -
activity and its I148M mutation results in loss of function. Biochim Biophys Acta.
1841, 574-580 (2014)
11.
Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that
confers susceptibility to nonalcoholic fatty liver disease. Nature Genetics 46, 352356 (2014)
12.
Luukkonen, P. K. et al. Impaired hepatic lipid synthesis from polyunsaturated
fatty acids in TM6SF2 E167K variant carriers with NAFLD. J Hepatol. 67, 128136 (2017)
13.
Lee, H. C. et al. Caenorhabditis elegans mboa-7, a member of the MBOAT family,
is required for selective incorporation of polyunsaturated fatty acids into
phosphatidylinositol. Mol Biol Cell. 19, 1174-1184 (2008)
14.
Mancina, R.M. et al. The MBOAT7-TMC4 Variant rs641738 Increases Risk of
Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Gastroenterology 150, 1219-1230 (2016)
15.
Luukkonen, P. K. et al. The MBOAT7 variant rs641738 alters hepatic
phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in
humans. J Hepatol. 65, 1263-1265 (2016).
16.
Buch, S. et al. A genome-wide association study confirms PNPLA3 and identifies
TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nature Genetics
47, 1443-1448 (2015)
17.
Thabet, K. et al.
The membrane‐bound O‐acyltransferase domain‐containing 7
variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
- 48 -
Hepatology 65, 1840-1850 (2017)
18.
Thabet, K. et al. MBOAT7 rs641738 increases risk of liver inflammation and
transition to fibrosis in chronic hepatitis C. Nature communications 7, 12757
(2016).
19.
Meer, G. V. et al. Membrane lipids: where they are and how they behave. Nature
Reviews Molecular Cell Biology 9, 112-124 (2008)
20.
Jungalwala, F. et al. Compositional and molecular species analysis of
phospholipids by high performance liquid chromatography coupled with chemical
ionization mass spectrometry. J Lipid Res. 25, 738-749 (1984).
21.
Johansen, A. et al. Mutations in MBOAT7, Encoding Lysophosphatidylinositol
Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and
Autistic Features. Am J Hum Genet. 99, 912-916 (2016).
22.
Lee,
H.
C.
et
al.
LPIAT1
regulates
arachidonic
acid
content
in
phosphatidylinositol and is required for cortical lamination in mice. Mol Biol Cell.
23, 4689-4700 (2012)
23.
Kubo, T. Physiological role of phosphatidylinositol selective acyltransferase
LPIAT1. Tokyo University, 2016, Ph.D. thesis.
24.
Ichi, I. et al. Identification of genes and pathways involved in the synthesis of
Mead acid (20:3n-9), an indicator of essential fatty acid deficiency. Biochim
Biophys Acta. 1841, 204-213 (2014)
25.
Ipsen, D. H. et al. Molecular mechanisms of hepatic lipid accumulation in nonalcoholic fatty liver disease. Cellular and Molecular Life Sciences 75, 3313-3327
- 49 -
(2018)
26.
Millar, J. S. et al. Determining hepatic triglyceride production in mice:
comparison of poloxamer 407 with Triton WR-1339. J Lipid Res. 46, 2023-2028
(2005)
27.
Field, F. J. et al. Regulation of triglyceride-rich lipoprotein secretion by fatty acids
in CaCo-2 cells. J Lipid Res. 11, 1427-1437 (1988)
28.
Koonen, D. P. Y. et al. Increased hepatic CD36 expression contributes to
dyslipidemia associated with diet-induced obesity. Diabetes 56, 2863-2871
(2007).
29.
Postic, C. & Girard, J. The role of the lipogenic pathway in the development of
hepatic steatosis. Diabetes Metab. 34, 643-648 (2008).
30.
D’Souza, K. et al. Distinct Properties of the Two Isoforms of CDP-Diacylglycerol
Synthase. Biochemistry 53, 7358-7367 (2014).
31.
Hallcher, L. M. & Sherman, W. R. The Effects of Lithium Ion and Other Agents
on the Activity of myo-Inositol-1-phosphatasefrom Bovine Brain. The journal of
Biological Chemistry 255, 10896-10901 (1980)
32.
Okuno, T. et al. Altered eicosanoid production and phospholipid remodeling
during cell culture. Journal of Lipid Research 59, 542-549 (2018)
33.
Helsley, R. N. et al. Obesity-linked suppression of membrane-bound Oacyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. eLife 8,
e49882 (2019)
34.
Meroni, M. et al. Mboat7 down-regulation by hyper-insulinemia induces fat
- 50 -
accumulation in hepatocytes. EBioMedicine 52, 102658 (2020)
35.
Xia, M. et al. Hepatic deletion of Mboat7 (Lpiat1) causes activation of SREBP1c and fatty liver. J Lipid Res. Aug 28 (2020) doi: 10.1194/jlr.RA120000856.
Online ahead of print.
36.
Nakamura, Y. & Fukami, K. Regulation and physiological functions of
mammalian phospholipase C. The Journal of Biochamistry 161, 315-321 (2017)
37.
Veen, M. V. et al. Negative regulation of urokinase receptor activity by a GPIspecific phospholipase C in breast cancer cells. eLife 6, e23649 (2017)
38.
Jaber, N. et al. Class III PI3K Vps34 plays an essential role in autophagy and in
heart and liver function. Proc Natl Acad Sci. 109, 2003-2008 (2012)
39.
Stiles, B. et al. Liver-specific deletion of negative regulator Pten results in fatty
liver and insulin hypersensitivity. Proc Natl Acad Sci. 101, 2082-2087 (2003)
40.
Thangapandi, V. R. et al. Loss of hepatic Mboat7 leads to liver fibrosis. Gut
Published online first: 26 June 2020. doi:10.1136/gutjnl-2020-320853
41.
Tanaka, Y. et al. LPIAT1/MBOAT7 depletion increases triglyceride synthesis
fueled by high phosphatidylinositol turnover. Gut 70, 180-193 (2021)
42.
Ran F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nature
Protocols 8, 2281-2308 (2013).
43.
Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification.
Can J Boichem Physiol. 37, 911–917 (1959).
44.
Shimanaka, Y. et al. Omega-3 fatty acid epoxides are autocrine mediators that
control the magnitude of IgE-mediated mast cell activation. Nature Medicine 23,
- 51 -
1287–1297 (2017).
45.
Ariyama, H. et al. Decrease in membrane phospholipid unsaturation induces
unfolded protein response. J Biol Chem. 285, 22027-22035 (2010)
46.
Huynh, F. K. et al. Measurement of fatty acid oxidation rates in animal tissues and
cell lines. Methods Enzymol. 542, 391-405 (2014).
47.
Liu, X. et al. Simultaneous determination of inositol and inositol phosphates in
complex biological matrices: quantitative ion-exchange chromatography/tandem
mass spectrometry. Rapid Commun Mass Spectrom. 23, 705-712 (2009).
48.
Azevedo, C. & Saiardi, A. Extraction and analysis of soluble inositol
polyphosphates from yeast. Nature Protocol 1, 2416-2422 (2006)
49.
Duong, Q. H. et al. Quantification of inositol phosphates in almond meal and
almond brown skins by HPLC/ESI/MS. Food Chem. 229, 84-92 (2007).
50.
Kubota, N. et al. Adiponectin stimulates AMP-activated protein kinase in the
hypothalamus and increases food intake. Cell Metabolism 6, 55-68 (2007).
- 52 -
Acknowledgements
本研究を進めるにあたり、終始御指導くださりました東京⼤学⼤学院 薬学系研究科
衛⽣化学教室の⻘⽊淳賢 教授、河野望 准教授、(独) 医療品医療機器総合機構 審査セ
ンター・レギュラトリーサイエンスセンターの新井洋由 センター⻑、University of
California Los Angeles の嶋中雄太 研究員に⼼より感謝致します。特に⽇々の研究⽅針
を直接指導してくださった河野望 准教授、嶋中雄太 研究員には⼤変お世話になりまし
た。先⽣⽅との⽇々の議論により研究者として⼤きく成⻑することができました。これ
までのご指導、ご鞭撻に深く感謝致します。
マウスの代謝解析について、共同研究を⾏なっていただいた東京⼤学⼤学院 医学系
研究科 内科学専攻 ⽣体防御腫瘍内科学講座 ⼭内敏正 先⽣、公共財団法⼈朝⽇⽣命成
⼈病研究所 窪⽥哲也 先⽣、東京⼤学 医学部付属病院 窪⽥直⼈ 先⽣に⼼より感謝致
します。また論⽂の投稿に際し、Gothenburg University の Stefano Romeo 教授、およ
び研究グループの皆様には⼤変お世話になりました。⼼より感謝申し上げます。
⽇々の研究⽣活を共にし、本研究を様々な⾯で⽀えて下さいました衛⽣化学教室の皆
様に⼼より感謝致します。優秀で賑やかな皆様に囲まれて、とても充実した研究室⽣活
を送ることができました。また⽇々の研究⽣活を⽀えてくださりました、⾼⽥祥恵さん、
伏間貴⼦さん、⼤澤由季⼦さん、道村彩美さんに深く感謝致します。
最後に、いつも応援し、学⽣⽣活を⽀えてくれた⽗、⺟、妹、祖⽗、祖⺟に⼼より感
謝します。皆様のおかげで研究に打ち込むことができ充実した 3 年間を過ごすことがで
きました。本当にありがとうございました。
2021 年 1 ⽉ 7 ⽇
- 53 -
...
論文の公開元へ
